<p>Bryn Mawr Trust Advisors LLC 在最近向证券交易委员会提交的 13F 文件中表示，在第四季度将其在联合健康集团（NYSE:UNH - 免费报告）的持股减少了 10.4%。该基金在季度内出售了 3,211 股后，持有该医疗保健巨头的 27,789 股。Bryn Mawr Trust Advisors LLC 在联合健康集团的持股在最近一个季度末价值为 9,174,000 美元。</p>
<p>获取 <strong>联合健康集团</strong> 的提醒：</p>
<ul>
<li>3 只医疗保健股票将从一项重大美好法案中受益</li>
</ul>
<p>其他大型投资者最近也调整了对该公司的持股。Beacon Financial Strategies CORP 在第四季度购买了价值约 26,000 美元的联合健康集团新股份。Anfield Capital Management LLC 在第四季度将其在联合健康集团的持股增加了 220.0%。Anfield Capital Management LLC 现在持有该医疗保健巨头的 80 股股票，价值 26,000 美元，此前在上个季度又购买了 55 股。Joseph Group Capital Management 在第四季度购买了价值约 27,000 美元的联合健康集团新股份。Foster Dykema Cabot &amp; Partners LLC 在第三季度将其在联合健康集团的持股增加了 69.4%。Foster Dykema Cabot &amp; Partners LLC 现在持有该医疗保健巨头的 83 股股票，价值 29,000 美元，此前在上个季度又购买了 34 股。最后，1248 Management LLC 在第三季度购买了价值约 29,000 美元的联合健康集团新股份。机构投资者持有该公司 87.86% 的股票。</p>
<h2>联合健康集团的内部买卖</h2>
<p>在其他消息中，首席执行官 Patrick Hugh Conway 于 4 月 23 日星期四出售了 800 股公司的股票。该股票以平均价格 355.00 美元出售，总交易额为 284,000.00 美元。交易完成后，首席执行官直接持有该公司 17,805 股股票，价值 6,320,775 美元。这笔交易代表了他们持股的 4.30% 的减少。该出售在向证券交易委员会的法律文件中披露，该文件可通过 SEC 网站获取。0.28% 的股票由内部人士持有。</p>
<h2>联合健康集团的价格表现</h2>
<ul>
<li>UNH 股东可能迎来健康反弹</li>
</ul>
<p>UNH 周五开盘价为 379.49 美元。该股票的 50 日简单移动平均线为 304.54 美元，200 日简单移动平均线为 316.98 美元。该公司的流动比率为 0.80，速动比率为 0.79，债务与股本比率为 0.69。该公司的市值为 3446.3 亿美元，市盈率为 28.66，市盈增长比率为 1.64，贝塔值为 0.64。联合健康集团的 12 个月低点为 234.60 美元，12 个月高点为 387.21 美元。</p>
<p>联合健康集团（NYSE:UNH - 获取免费报告）最近于 4 月 21 日星期二发布了季度财报。该医疗保健巨头报告每股收益（EPS）为 7.23 美元，超出分析师共识预期的 6.76 美元，超出幅度为 0.47 美元。联合健康集团的股本回报率为 14.65%，净利润率为 2.68%。该公司在季度内的收入为 1,116.5 亿美元，而共识预期为 1,098.4 亿美元。在去年同期，该公司每股收益为 7.20 美元。该公司的季度收入较去年同期增长了 2.0%。联合健康集团已将其 2026 财年的指导目标设定为 18.250- 每股收益。研究分析师预测联合健康集团将在当前财年发布 18.29 美元的每股收益。</p>
<h2>联合健康集团宣布分红</h2>
<ul>
<li>MarketBeat 周回顾 – 01/26 - 01/30</li>
</ul>
<p>该公司最近还宣布了季度分红，已于 3 月 17 日星期二支付。3 月 9 日星期一的股东获得每股 2.21 美元的分红。除息日为 3 月 9 日星期一。这代表着每年 8.84 美元的分红和 2.3% 的分红收益率。联合健康集团的分红支付比率（DPR）目前为 66.77%。</p>
<h2>联合健康集团新闻摘要</h2>
<p>以下是本周影响联合健康集团的主要新闻：</p>
<ul>
<li>积极情绪：联合健康表示将取消 30% 医疗服务的事先授权，这可能是一个对投资者友好的举措，可能简化护理流程并减少对保险公司批准的投诉。联合健康将取消 30% 医疗服务的事先授权</li>
<li>积极情绪：Erste Group Bank 上调了联合健康的 2027 财年收益预期，显示出对长期盈利能力的信心，并维持对该股票的买入评级。</li>
<li>中性情绪：联合健康在关于价值股票和复苏前景的评论中被提及，这可能支持投资者的兴趣，但似乎并不是直接的基本面催化剂。联合健康：关注复苏的行动</li>
<li>中性情绪：Zacks Research 下调了近期和 2027 财年第四季度的收益预期，这是一种阻力，但这些修订并不像公司的政策变化那样重要，可能反映出更谨慎的预测，而不是重大恶化。乐观的季度业绩：3 家公司上调了指导。</li>
</ul>
<h2>分析师评级变动</h2>
<p>联合健康集团（UnitedHealth Group）近期成为多份研究报告的主题。Truist Financial 在 4 月 22 日的研究报告中重申了对联合健康集团的 “买入” 评级，并将其目标股价从 370.00 美元上调至 395.00 美元。Oppenheimer 将联合健康集团的目标股价从 385.00 美元提高至 405.00 美元，并在 4 月 22 日的研究报告中给予该公司 “跑赢大盘” 的评级。Robert W. Baird 在 4 月 22 日的研究报告中将联合健康集团的目标股价从 278.00 美元上调至 287.00 美元，并给予该公司 “表现不佳” 的评级。瑞银集团（UBS Group）在 1 月 28 日的研究报告中将联合健康集团的目标股价从 430.00 美元下调至 410.00 美元，并对该公司设定了 “买入” 评级。最后，Argus 在 4 月 22 日的研究报告中将联合健康集团的评级从 “持有” 上调至 “买入”，并为该公司设定了 400.00 美元的目标股价。一位研究分析师对该股票给予了强烈买入评级，二十位给予了买入评级，七位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，联合健康集团目前的平均评级为 “适度买入”，共识目标股价为 378.88 美元。</p>
<p><strong>查看我们关于联合健康集团的最新股票报告</strong></p>
<h2>联合健康集团简介</h2>
<p>（免费报告）</p>
<p>联合健康集团（UnitedHealth Group Inc）是一家多元化的医疗保健公司，总部位于明尼苏达州的明尼通卡，主要运营两个业务平台：联合医疗（UnitedHealthcare）和 Optum。该公司成立于 1977 年，向个人、雇主、政府实体和其他组织提供广泛的健康福利和医疗服务。其业务涵盖商业雇主赞助的计划、个人以及医疗保险和医疗补助项目，以及为美国及部分国际市场的客户和医疗系统提供服务。</p>
<p>联合医疗是公司的福利业务，负责管理健康计划和网络，维护与提供者的关系，并为雇主、个人和政府赞助的项目提供保险产品。</p>
<h2>精选文章</h2>
<ul>
<li>五只我们更看好的股票，胜过联合健康集团</li>
<li>巴菲特花了 60 年忽视科技，账单即将到来</li>
<li>对黄金感到兴奋但不确定其走势？试试这三种方法</li>
<li>美元跌至三年低点：三家出口商悄然印钞</li>
<li>水务基础设施：为什么这个乏味的行业可能会变得令人兴奋</li>
</ul>
<p><strong>想看看其他对 UNH 持有的对冲基金吗？</strong> 访问 HoldingsChannel.com，获取联合健康集团（UnitedHealth Group Incorporated，NYSE:UNH - 免费报告）的最新 13F 文件和内部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元于联合健康集团吗？</h2>
<p>在考虑联合健康集团之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前立即购买……而联合健康集团并不在名单上。</p>
<p>虽然联合健康集团目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

联合健康

UNHG

<p>Bryn Mawr Trust Advisors LLC 在第四季度减少了对联合健康集团（NYSE:UNH）10.4% 的持股，持有 27,789 股，价值 917 万美元。其他投资者也调整了他们的持仓，机构持股比例为 87.86%。首席执行官 Patrick Hugh Conway 出售了 800 股，减少了 4.3% 的持股。联合健康报告第一季度每股收益为 7.23 美元，超出预期，并宣布每股季度分红为 2.21 美元。该股票开盘价为 379.49 美元，市值为 3446.3 亿美元，市盈率为 28.66</p>

<p>Bryn Mawr Trust Advisors LLC lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 10.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 27,789 shares of the healthcare conglomerate's stock after selling 3,211 shares during the quarter. Bryn Mawr Trust Advisors LLC's holdings in UnitedHealth Group were worth $9,174,000 at the end of the most recent quarter.</p>
<div class="lb-trans"><p>Bryn Mawr Trust Advisors LLC 在最近向证券交易委员会提交的 13F 文件中表示，在第四季度将其在联合健康集团（NYSE:UNH - 免费报告）的持股减少了 10.4%。该基金在季度内出售了 3,211 股后，持有该医疗保健巨头的 27,789 股。Bryn Mawr Trust Advisors LLC 在联合健康集团的持股在最近一个季度末价值为 9,174,000 美元。</p>
</div><p>Get <strong>UnitedHealth Group</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>联合健康集团</strong> 的提醒：</p>
</div><ul>
<li>3 Healthcare Stocks Set to Benefit From the One Big Beautiful Bill</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只医疗保健股票将从一项重大美好法案中受益</li>
</ul>
</div><p>Other large investors have also recently modified their holdings of the company. Beacon Financial Strategies CORP purchased a new stake in UnitedHealth Group during the fourth quarter valued at about $26,000. Anfield Capital Management LLC raised its position in UnitedHealth Group by 220.0% during the fourth quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate's stock valued at $26,000 after purchasing an additional 55 shares in the last quarter. Joseph Group Capital Management purchased a new stake in UnitedHealth Group in the fourth quarter worth approximately $27,000. Foster Dykema Cabot &amp; Partners LLC grew its position in UnitedHealth Group by 69.4% during the third quarter. Foster Dykema Cabot &amp; Partners LLC now owns 83 shares of the healthcare conglomerate's stock valued at $29,000 after acquiring an additional 34 shares during the last quarter. Finally, 1248 Management LLC bought a new position in UnitedHealth Group during the third quarter valued at approximately $29,000. Institutional investors own 87.86% of the company's stock.</p>
<div class="lb-trans"><p>其他大型投资者最近也调整了对该公司的持股。Beacon Financial Strategies CORP 在第四季度购买了价值约 26,000 美元的联合健康集团新股份。Anfield Capital Management LLC 在第四季度将其在联合健康集团的持股增加了 220.0%。Anfield Capital Management LLC 现在持有该医疗保健巨头的 80 股股票，价值 26,000 美元，此前在上个季度又购买了 55 股。Joseph Group Capital Management 在第四季度购买了价值约 27,000 美元的联合健康集团新股份。Foster Dykema Cabot &amp; Partners LLC 在第三季度将其在联合健康集团的持股增加了 69.4%。Foster Dykema Cabot &amp; Partners LLC 现在持有该医疗保健巨头的 83 股股票，价值 29,000 美元，此前在上个季度又购买了 34 股。最后，1248 Management LLC 在第三季度购买了价值约 29,000 美元的联合健康集团新股份。机构投资者持有该公司 87.86% 的股票。</p>
</div><h2>Insider Buying and Selling at UnitedHealth Group</h2>
<div class="lb-trans"><h2>联合健康集团的内部买卖</h2>
</div><p>In other news, CEO Patrick Hugh Conway sold 800 shares of the firm's stock in a transaction on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total transaction of $284,000.00. Following the completion of the transaction, the chief executive officer directly owned 17,805 shares in the company, valued at $6,320,775. This trade represents a 4.30% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available through the SEC website. 0.28% of the stock is owned by insiders.</p>
<div class="lb-trans"><p>在其他消息中，首席执行官 Patrick Hugh Conway 于 4 月 23 日星期四出售了 800 股公司的股票。该股票以平均价格 355.00 美元出售，总交易额为 284,000.00 美元。交易完成后，首席执行官直接持有该公司 17,805 股股票，价值 6,320,775 美元。这笔交易代表了他们持股的 4.30% 的减少。该出售在向证券交易委员会的法律文件中披露，该文件可通过 SEC 网站获取。0.28% 的股票由内部人士持有。</p>
</div><h2>UnitedHealth Group Price Performance</h2>
<div class="lb-trans"><h2>联合健康集团的价格表现</h2>
</div><ul>
<li>A Healthy Rebound Could Lie Ahead for UNH Shareholders</li>
</ul>
<div class="lb-trans"><ul>
<li>UNH 股东可能迎来健康反弹</li>
</ul>
</div><p>UNH opened at $379.49 on Friday. The stock has a fifty day simple moving average of $304.54 and a two-hundred day simple moving average of $316.98. The company has a current ratio of 0.80, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69. The company has a market cap of $344.63 billion, a price-to-earnings ratio of 28.66, a price-to-earnings-growth ratio of 1.64 and a beta of 0.64. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $387.21.</p>
<div class="lb-trans"><p>UNH 周五开盘价为 379.49 美元。该股票的 50 日简单移动平均线为 304.54 美元，200 日简单移动平均线为 316.98 美元。该公司的流动比率为 0.80，速动比率为 0.79，债务与股本比率为 0.69。该公司的市值为 3446.3 亿美元，市盈率为 28.66，市盈增长比率为 1.64，贝塔值为 0.64。联合健康集团的 12 个月低点为 234.60 美元，12 个月高点为 387.21 美元。</p>
</div><p>UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $6.76 by $0.47. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The business had revenue of $111.65 billion during the quarter, compared to the consensus estimate of $109.84 billion. During the same quarter in the prior year, the company earned $7.20 earnings per share. The firm's quarterly revenue was up 2.0% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. Research analysts predict that UnitedHealth Group Incorporated will post 18.29 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>联合健康集团（NYSE:UNH - 获取免费报告）最近于 4 月 21 日星期二发布了季度财报。该医疗保健巨头报告每股收益（EPS）为 7.23 美元，超出分析师共识预期的 6.76 美元，超出幅度为 0.47 美元。联合健康集团的股本回报率为 14.65%，净利润率为 2.68%。该公司在季度内的收入为 1,116.5 亿美元，而共识预期为 1,098.4 亿美元。在去年同期，该公司每股收益为 7.20 美元。该公司的季度收入较去年同期增长了 2.0%。联合健康集团已将其 2026 财年的指导目标设定为 18.250- 每股收益。研究分析师预测联合健康集团将在当前财年发布 18.29 美元的每股收益。</p>
</div><h2>UnitedHealth Group Announces Dividend</h2>
<div class="lb-trans"><h2>联合健康集团宣布分红</h2>
</div><ul>
<li>MarketBeat Week in Review – 01/26 - 01/30</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 01/26 - 01/30</li>
</ul>
</div><p>The business also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th were issued a dividend of $2.21 per share. The ex-dividend date was Monday, March 9th. This represents a $8.84 annualized dividend and a dividend yield of 2.3%. UnitedHealth Group's dividend payout ratio (DPR) is presently 66.77%.</p>
<div class="lb-trans"><p>该公司最近还宣布了季度分红，已于 3 月 17 日星期二支付。3 月 9 日星期一的股东获得每股 2.21 美元的分红。除息日为 3 月 9 日星期一。这代表着每年 8.84 美元的分红和 2.3% 的分红收益率。联合健康集团的分红支付比率（DPR）目前为 66.77%。</p>
</div><h2>UnitedHealth Group News Summary</h2>
<div class="lb-trans"><h2>联合健康集团新闻摘要</h2>
</div><p>Here are the key news stories impacting UnitedHealth Group this week:</p>
<div class="lb-trans"><p>以下是本周影响联合健康集团的主要新闻：</p>
</div><ul>
<li>Positive Sentiment: UnitedHealth said it will eliminate prior authorization for 30% of healthcare services, a potentially investor-friendly move that may streamline care and reduce complaints about insurer approvals. UnitedHealth to Eliminate Prior Authorization for 30% of Healthcare Services</li>
<li>Positive Sentiment: Erste Group Bank raised its FY2027 earnings estimate for UnitedHealth, signaling confidence in longer-term profitability, and kept a Buy rating on the stock.</li>
<li>Neutral Sentiment: UnitedHealth was highlighted in commentary about value stocks and recovery prospects, which may support investor interest but does not appear to be a direct fundamental catalyst. UnitedHealth: Watch The Recovery In Action</li>
<li>Neutral Sentiment: Zacks Research cut near-term and Q4 2027 earnings estimates, which is a headwind, but the revisions were not as central as the company’s policy change and may reflect more cautious forecasting rather than a major deterioration. Bullish Quarterly Results: 3 Companies Raising Guidance</li>
</ul>
<div class="lb-trans"><ul>
<li>积极情绪：联合健康表示将取消 30% 医疗服务的事先授权，这可能是一个对投资者友好的举措，可能简化护理流程并减少对保险公司批准的投诉。联合健康将取消 30% 医疗服务的事先授权</li>
<li>积极情绪：Erste Group Bank 上调了联合健康的 2027 财年收益预期，显示出对长期盈利能力的信心，并维持对该股票的买入评级。</li>
<li>中性情绪：联合健康在关于价值股票和复苏前景的评论中被提及，这可能支持投资者的兴趣，但似乎并不是直接的基本面催化剂。联合健康：关注复苏的行动</li>
<li>中性情绪：Zacks Research 下调了近期和 2027 财年第四季度的收益预期，这是一种阻力，但这些修订并不像公司的政策变化那样重要，可能反映出更谨慎的预测，而不是重大恶化。乐观的季度业绩：3 家公司上调了指导。</li>
</ul>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><p>UNH has been the topic of a number of recent research reports. Truist Financial reiterated a &#34;buy&#34; rating and set a $395.00 price target (up from $370.00) on shares of UnitedHealth Group in a research report on Wednesday, April 22nd. Oppenheimer increased their price target on shares of UnitedHealth Group from $385.00 to $405.00 and gave the company an &#34;outperform&#34; rating in a research report on Wednesday, April 22nd. Robert W. Baird increased their price target on shares of UnitedHealth Group from $278.00 to $287.00 and gave the company an &#34;underperform&#34; rating in a research report on Wednesday, April 22nd. UBS Group dropped their price objective on UnitedHealth Group from $430.00 to $410.00 and set a &#34;buy&#34; rating for the company in a research note on Wednesday, January 28th. Finally, Argus raised UnitedHealth Group from a &#34;hold&#34; rating to a &#34;buy&#34; rating and set a $400.00 price objective for the company in a research note on Wednesday, April 22nd. One research analyst has rated the stock with a Strong Buy rating, twenty have given a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, UnitedHealth Group currently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $378.88.</p>
<div class="lb-trans"><p>联合健康集团（UnitedHealth Group）近期成为多份研究报告的主题。Truist Financial 在 4 月 22 日的研究报告中重申了对联合健康集团的 “买入” 评级，并将其目标股价从 370.00 美元上调至 395.00 美元。Oppenheimer 将联合健康集团的目标股价从 385.00 美元提高至 405.00 美元，并在 4 月 22 日的研究报告中给予该公司 “跑赢大盘” 的评级。Robert W. Baird 在 4 月 22 日的研究报告中将联合健康集团的目标股价从 278.00 美元上调至 287.00 美元，并给予该公司 “表现不佳” 的评级。瑞银集团（UBS Group）在 1 月 28 日的研究报告中将联合健康集团的目标股价从 430.00 美元下调至 410.00 美元，并对该公司设定了 “买入” 评级。最后，Argus 在 4 月 22 日的研究报告中将联合健康集团的评级从 “持有” 上调至 “买入”，并为该公司设定了 400.00 美元的目标股价。一位研究分析师对该股票给予了强烈买入评级，二十位给予了买入评级，七位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，联合健康集团目前的平均评级为 “适度买入”，共识目标股价为 378.88 美元。</p>
</div><p><strong>Check Out Our Latest Stock Report on UnitedHealth Group</strong></p>
<div class="lb-trans"><p><strong>查看我们关于联合健康集团的最新股票报告</strong></p>
</div><h2>UnitedHealth Group Profile</h2>
<div class="lb-trans"><h2>联合健康集团简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.</p>
<div class="lb-trans"><p>联合健康集团（UnitedHealth Group Inc）是一家多元化的医疗保健公司，总部位于明尼苏达州的明尼通卡，主要运营两个业务平台：联合医疗（UnitedHealthcare）和 Optum。该公司成立于 1977 年，向个人、雇主、政府实体和其他组织提供广泛的健康福利和医疗服务。其业务涵盖商业雇主赞助的计划、个人以及医疗保险和医疗补助项目，以及为美国及部分国际市场的客户和医疗系统提供服务。</p>
</div><p>UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.</p>
<div class="lb-trans"><p>联合医疗是公司的福利业务，负责管理健康计划和网络，维护与提供者的关系，并为雇主、个人和政府赞助的项目提供保险产品。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than UnitedHealth Group</li>
<li>Buffett Spent 60 Years Ignoring Tech and the Bill Is Coming Due</li>
<li>Excited About Gold But Unsure of Its Trajectory? Try These 3 Approaches</li>
<li>Dollar at a 3-Year Low: 3 Exporters Quietly Printing Money</li>
<li>Water Infrastructure: Why This Boring Sector Could Get Exciting</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过联合健康集团</li>
<li>巴菲特花了 60 年忽视科技，账单即将到来</li>
<li>对黄金感到兴奋但不确定其走势？试试这三种方法</li>
<li>美元跌至三年低点：三家出口商悄然印钞</li>
<li>水务基础设施：为什么这个乏味的行业可能会变得令人兴奋</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding UNH?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对 UNH 持有的对冲基金吗？</strong> 访问 HoldingsChannel.com，获取联合健康集团（UnitedHealth Group Incorporated，NYSE:UNH - 免费报告）的最新 13F 文件和内部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=UNH"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in UnitedHealth Group Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元于联合健康集团吗？</h2>
</div><p>Before you consider UnitedHealth Group, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑联合健康集团之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前立即购买……而联合健康集团并不在名单上。</p>
</div><p>While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然联合健康集团目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Bryn Mawr Trust Advisors LLC 减少了在联合健康集团（UnitedHealth Group Incorporated）$UNH 的持仓